Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality -4% Improvement Relative Risk c19hcq.org Kokturk et al. HCQ for COVID-19 LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 1,500 patients in Turkey No significant difference in mortality Kokturk et al., Respiratory Medicine, doi:10.1016/j.rmed.2021.106433 Favors HCQ Favors control
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
Kokturk et al., Respiratory Medicine, doi:10.1016/j.rmed.2021.106433
Kokturk et al., The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients, Respiratory Medicine, doi:10.1016/j.rmed.2021.106433
Apr 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 1,500 hospitalized late stage (median SaO2 87.7) patients in Turkey, showing no significant difference with HCQ treatment.
risk of death, 3.8% higher, RR 1.04, p = 0.97, treatment 62 of 1,382 (4.5%), control 5 of 118 (4.2%), adjusted per study, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Kokturk et al., 28 Apr 2021, retrospective, database analysis, Turkey, peer-reviewed, 68 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Respiratory Medicine 183 (2021) 106433 Contents lists available at ScienceDirect Respiratory Medicine journal homepage: www.elsevier.com/locate/rmed Original Research The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients Nurdan Kokturk a, *, Cenk Babayigit b, Seval Kul c, Pelin Duru Cetinkaya d, Sibel Atis Nayci e, Serap Argun Baris f, Oguz Karcioglu g, Pinar Aysert h, Ilim Irmak i, Aycan Akbas Yuksel j, Yonca Sekibag k, Oya Baydar Toprak l, Emel Azak m, Sait Mulamahmutoglu k, Caglar Cuhadaroglu n, Aslihan Demirel o, Bugra Kerget p, Burcu Baran Ketencioglu q, Hasan Selcuk Ozger h, Gulcihan Ozkan r, s, Zeynep Ture t, Begum Ergan u, Vildan Avkan Oguz v, Oguz Kilinc u, Merve Ercelik w, Tansu Ulukavak Ciftci a, Ozlem Alici x, Esra Nurlu Temel y, Ozlem Ataoglu w, Asena Aydin z, Dilek Cetiner Bahcetepe z, Yusuf Taha Gullu aa, Fusun Fakili ab, Figen Deveci ac, Neslihan Kose ad, Muge Meltem Tor ae, Gulsah Gunluoglu af, Sedat Altin af, Teyfik Turgut ac, Tibel Tuna aa, Onder Ozturk ag, Oner Dikensoy ah, Pinar Yildiz Gulhan w, Ilknur Basyigit f, Hasim Boyaci f, I. Kivilcim Oguzulgen a, Sermin Borekci k, Bilun Gemicioglu k, Firat Bayraktar ai, Osman Elbek aj, Ismail Hanta l, Hacer Kuzu Okur n, Gulseren Sagcan n, Oguz Uzun aa, Metin Akgun p, Goksel Altinisik ak, Berna Dursun al, Ebru Cakir Edis am, Erkmen Gulhan an, Fusun Oner Eyuboglu ao, Okkes Gultekin ap, Yavuz Havlucu ap, Metin Ozkan al, Aysin Sakar Coskun ap, Abdullah Sayiner aq, Ali Fuat Kalyoncu i, Oya Itil u, Hasan Bayram ar a Department of Pulmonary Medicine, Faculty of Medicine, Gazi University, Ankara, Turkey Department of Pulmonary Medicine, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey Department of Biostatistics, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey d Department of Pulmonary Medicine, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey e Department of Pulmonary Medicine, Faculty of Medicine, Mersin University, Mersin, Turkey f Department of Pulmonary Medicine, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey g Department of Pulmonary Medicine, Halil Sıvgın Cubuk State Hospital, Ankara, Turkey h Department of Infectious Disease, Faculty of Medicine, Gazi University, Ankara, Turkey i Department of Pulmonary Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey j Department of Pulmonary Medicine, Faculty of Medicine, Ufuk University, Ankara, Turkey k Department of Pulmonary Disease, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey l Department of Pulmonary Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey m Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Kocaeli University, Kocaeli Turkey n Department of Pulmonary Medicine, Altunizade Acibadem Hospital, Istanbul, Turkey o Department of Infectious Disease, Kadikoy Florence Nightingale Hospital, Istanbul, Turkey p Department of Pulmonary Medicine, Faculty of Medicine, Ataturk University, Erzurum, Turkey q Department of Pulmonary Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey r Department of Pulmonary Medicine, Maslak Acibadem Hospital, Istanbul, Turkey s Operating Room Services Department, Nisantasi University, Vocational School, Istanbul, Turkey t Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey u Department of Pulmonary Medicine, Faculty of..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit